Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions

Rebecca L. Corwin, Francis H. Wojnicki

Research output: Contribution to journalArticlepeer-review

62 Scopus citations


Gamma-aminobutyric acid (GABA), dopamine, and opioids are implicated in impulse control, addiction and binge eating. Recent evidence suggests that sucrose alters the effects of GABAergic, dopaminergic, and opioid receptor ligands on consumption of a fatty food in a rat limited-access binge protocol. This study determined the independent effects of fat and sucrose on the efficacy of these ligands under limited-access conditions. Nonfood-deprived male Sprague-Dawley rats had 1 h access to fat (vegetable shortening) or sucrose (3.2, 10, or 32% w/v). Half had intermittent access (Monday, Wednesday, Friday) and half had daily access. Effects of baclofen (GABAB agonist), SCH 23390 (D1 antagonist), raclopride (D2 antagonist), and naltrexone (opioid antagonist) were assessed. Baclofen and naltrexone reduced fat intake regardless of the access schedule. Baclofen had no effect on sucrose intake; naltrexone reduced sucrose intake at higher doses than were required to reduce fat intake. Raclopride stimulated fat intake in intermittent-access rats and had no effect in daily-access rats; raclopride reduced sucrose intake in all groups. SCH 23390 reduced intake in a nonspecific manner. The results indicate the involvement of GABAB receptors in fat but not sucrose intake, and of D2 receptor dysfunction in rats with a history of bingeing on fat.

Original languageEnglish (US)
Pages (from-to)537-548
Number of pages12
JournalBehavioural Pharmacology
Issue number5-6
StatePublished - Sep 2009

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Psychiatry and Mental health


Dive into the research topics of 'Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions'. Together they form a unique fingerprint.

Cite this